Trials / Completed
CompletedNCT04133896
Circulating IL-6, Clusterin and Irisin in Obese Subjects
Circulating IL-6, Clusterin and Irisin in Obese Subjects With Different Grades of Obesity: Association With Insulin Resistance and Sexual Dimorphism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 176 (actual)
- Sponsor
- Rehab Werida · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
evaluate the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and their sexual dimorphism also identify the association of IL-6, clusterin and irisin with insulin resistance.
Detailed description
Aim: Firstly, this study aimed at assessing the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and evaluating their sexual dimorphism and secondly evaluate the association of IL-6, clusterin and irisin with insulin resistance. Method: This study was conducted on 176 non-diabetic subjects of both sexes. Participants were classified according to their sex into two groups; the male and female groups. The male group (88 men) was classified according to BMI into; group 1 (22 lean men), group 2 (22 class I obese men), group 3 (22 class II obese men), and group 4 (22 class III obese men). The female group (88 women) was also classified according to BMI exactly as the male group. Fasting blood glucose, fasting insulin, lipid panel, serum IL-6, clusterin and irisin levels were measured. One-way analysis of variance followed by Tukey's as post hoc test was used for comparison of variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | IL-6, Clusterin, Irisin Level | Blood samples to determine levels of Circulating IL-6, Clusterin and Irisin |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-06-01
- Completion
- 2019-06-30
- First posted
- 2019-10-21
- Last updated
- 2019-10-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04133896. Inclusion in this directory is not an endorsement.